Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $10.8500 (-2.78%) ($10.8500 - $10.8500) on Thu. Dec. 15, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.71% (three month average) | RSI | 37 | Latest Price | $10.8500(-2.78%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX advances 0.6% a day on average for past five trading days. | Weekly Trend | BCRX declines -7.1% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) URA(18%) XLK(18%) BLOK(17%) BND(17%) VUG(16%) | Factors Impacting BCRX price | BCRX will decline at least -1.855% in a week (0% probabilities). SMH(-27%) ARKG(-20%) VIXM(-9%) SHY(-9%) GLD(-9%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.855% (StdDev 3.71%) | Hourly BBV | -0.4 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-3.06(-128.2%) | Resistance Level | $11.8 | 5 Day Moving Average | $10.95(-0.91%) | 10 Day Moving Average | $11.1(-2.25%) | 20 Day Moving Average | $11.8(-8.05%) | To recent high | -23.7% | To recent low | 3.6% | Market Cap | $1.914b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |